Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Common Equity (2018 - 2025)

Outset Medical (OM) has disclosed Common Equity for 7 consecutive years, with $127.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 373.37% to $127.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $127.0 million, a 373.37% increase, with the full-year FY2025 number at $127.0 million, up 373.37% from a year prior.
  • Common Equity was $127.0 million for Q4 2025 at Outset Medical, down from $142.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $431.2 million in Q2 2021 to a low of $26.8 million in Q4 2024.
  • A 5-year average of $210.3 million and a median of $176.5 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: plummeted 78.18% in 2024, then skyrocketed 373.37% in 2025.
  • Outset Medical's Common Equity stood at $374.1 million in 2021, then crashed by 34.24% to $246.0 million in 2022, then plummeted by 50.04% to $122.9 million in 2023, then tumbled by 78.18% to $26.8 million in 2024, then surged by 373.37% to $127.0 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Common Equity are $127.0 million (Q4 2025), $142.4 million (Q3 2025), and $154.8 million (Q2 2025).